Translation and Validation of Chinese COMPAT-SF
Key facts
- Who runs it
- Changhai Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 356 people, planned
- Started
- 10 Mar 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Record updated
- 8 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- 1. Diagnosed with chronic pancreatitis (CP) according to the Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis in China (2018 edition). Diagnosis can be confirmed by: •Primary diagnostic criteria: (i) Definitive imaging findings, and (ii) Histopathological confirmation. •Secondary diagnostic criteria: (i) Recurrent upper abdominal pain, (ii) Abnormal serum amylase levels, (iii) Pancreatic exocrine insufficiency, (iv) Pancreatic endocrine insufficiency, (v) Pathogenic gene mutations, and (vi) History of heavy alcohol consumption. •Diagnosis is confirmed if at least one primary criterion or two secondary criteria are met
- 2. Experience of pancreatic pain in the past 12 months
Who cannot take part
- Diagnosed with pancreatic cancer or other tumors
- Under 18 years of age
- No pancreatic-related pain
- Presence of communication or reading impairments
- Refusal to participate in the study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to translate, adapt, and test the reliability of a Chinese version of the Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) for people with chronic pancreatitis.
Read full original descriptionShow less
The study will answer these questions:
* Does the Chinese COMPAT-SF work well to measure pain in people with chronic pancreatitis? * Is the Chinese COMPAT-SF accurate and reliable over time?
Participants will:
* Complete the Chinese COMPAT-SF questionnaire two times, with a 2-week gap. * Answer additional pain-related questions using the Brief Pain Inventory (BPI) and the Izbicki Pain Score. * Participate in a follow-up to check if the questionnaire gives consistent results over time.
This study will help make sure that doctors in China have a useful and reliable tool to measure pain in people with chronic pancreatitis.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Translation and Validation of a Chinese Version of the Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) in Patients With Chronic Pancreatitis
- Record updated
- 8 April 2025